AstraZeneca 3rd dose increases antibody response against Omicron

London, Jan 13 (IANS) A third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron variant, according to a new trial publishe...

Become a proud member of 1947.com to access this content.